Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. (OTCQB: DPXCF) generates news that reflects its focus on structured products at the intersection of fixed-income and cryptocurrency markets. The company’s disclosures highlight product development, capital-raising transactions, and initiatives related to its Quantem Crypto Securities (QCS) program.
Recent announcements have emphasized non-brokered private placements of units composed of common shares and warrants, with proceeds intended for working capital, corporate overhead, or general corporate purposes. These updates often include details on warrant terms, related party participation, and the need for TSX Venture Exchange approval, offering insight into how DelphX funds its activities and manages its capital structure.
Another key theme in DelphX news is the evolution of its QCS hedging solution. The company has reported marketing efforts to digital-asset treasuries and institutional participants, interest from a U.S. primary dealer evaluating a proof-of-concept deployment, and due diligence by multiple crypto-asset treasuries. It has also announced a non-binding letter of intent with Belgravia Hartford Capital Inc. for a potential first commercial QCS transaction aimed at protecting corporate Bitcoin treasury holdings.
Corporate governance and compensation developments also appear in DelphX news, including stock option grants under its option plan and transitions in the Chief Financial Officer role. For investors and observers, the DPXCF news stream offers ongoing context on product commercialization efforts, financing activities, and the company’s positioning within structured credit and digital-asset hedging.
Users following DelphX news can review these recurring topics to monitor how the company advances its proprietary CPO, CRN, and QCS offerings, and how regulatory approvals, market conditions, and institutional engagement influence its trajectory.
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.
Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit includes one common share and one warrant exercisable at $0.07 for two years. Closing is subject to TSX Venture Exchange approval and a four-month-and-one-day hold period on securities. Net proceeds are intended for general corporate purposes.
DelphX also seeks TSXV approval to extend the exercise period of 5,422,221 warrants (exercise price $0.15) by one year to December 7, 2026. 1,611,111 of those warrants are held by related parties; the company says available exemptions under MI 61-101 apply.
DelphX (OTCQB: DPXCF) provided a shareholder update on its Quantem Crypto Securities (QCS) fully‑collateralized hedging solution on November 18, 2025. Since QCS marketing began in mid‑September 2025, Bitcoin moved from above US$115,000 to below US$90,000, highlighting demand for institutional hedges. QCS is described as fully collateralized, transparent, and structured to mitigate volatility and protect treasury assets.
The company says a U.S. primary dealer is evaluating a possible proof‑of‑concept and multiple digital‑asset treasuries are conducting due diligence and scenario testing, but implementation is not assured.
DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered private placement on November 14, 2025, issuing 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each unit includes one common share and one warrant.
Each warrant is exercisable for one common share at $0.08 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a hold period of four months plus one day. Net proceeds are intended for general corporate purposes.
DelphX (OTCQB: DPXCF; TSXV: DELX) intends to proceed with a non-brokered private placement of 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each Unit comprises one common share and one warrant. Each warrant entitles the holder to buy one common share at C$0.08 for a two-year period from issuance. Completion is subject to TSX Venture Exchange approval. Securities issued will be subject to a four months plus one day hold period. DelphX intends to use net proceeds for general corporate purposes.
DelphX (OTCQB: DPXCF) intends to seek TSX Venture Exchange approval to extend the exercise period of 3,483,668 share purchase warrants issued Nov 1, 2023, exercisable at $0.20 per common share.
The proposed amendment would extend the warrants by one year to November 1, 2026; all other terms remain unchanged and the extension is subject to TSXV acceptance.
The company disclosed 866,667 warrants are held by related parties and classified the amendment as a related party transaction under MI 61-101 and TSXV Policy 5.9, while noting exemptions apply because the warrants' fair market value does not exceed 25% of market capitalization.
DelphX (OTCQB: DPXCF) closed a non‑brokered private placement on October 8, 2025, issuing 1,500,000 Units at C$0.05 per Unit for gross proceeds of C$75,000. Each Unit includes one common share and one warrant exercisable at $0.08 for two years.
An insider subscribed for 1,000,000 Units, triggering related‑party disclosure; DelphX relied on MI 61‑101 exemptions because the issuance and cash paid did not exceed 25% of market capitalization. Finder's fees of $3,500 and 70,000 finder's warrants (exercisable at $0.08 for two years) were issued. Securities are subject to a four months plus one day hold period and TSXV approval.
DelphX (OTCQB: DPXCF) announced a non-brokered unit private placement of 1,500,000 units at C$0.05 per unit for aggregate gross proceeds of C$75,000. Each unit includes one common share and one warrant exercisable at $0.08 for two years. An insider will subscribe for 1,000,000 units, making the Offering a related party transaction; DelphX will rely on MI 61-101 exemptions because the issuance and cash received do not exceed 25% of market capitalization. The company will pay cash finders' fees and issue finders' warrants exercisable at $0.08 for two years. Closing is subject to TSX Venture Exchange approval and securities will be subject to a four-month-plus-one-day hold. Net proceeds will be used for general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) provided an update on its Quantem Crypto Securities (QCS) program. The company's fully collateralized QCS offering is currently under evaluation by multiple digital asset treasuries and hedge funds for portfolio inclusion.
The company will attend the Bitcoin Treasuries Conference in New York to advance discussions with potential first adopters and partners, expecting initial alignments by month-end. Additionally, DelphX is exploring the establishment of its own digital asset treasury that would incorporate QCS as a direct downside hedge.
QCS is positioned as one of the few Wall Street-originated structured products for decentralized markets, offering institutional investors downside protection against cryptocurrency price declines while eliminating counterparty risk.
DelphX Capital Markets (OTCQB: DPXCF) has completed an additional issuance of 1,000,000 units at C$0.05 per unit, raising C$50,000 in a non-brokered private placement. This brings the total placement to 6,000,000 units for C$300,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years.
Insiders participated by subscribing for 1,000,000 units. The company also granted 1,800,000 stock options with a two-year maturity, exercisable at C$0.08 per share. The private placement proceeds will be used for general corporate purposes.